In a significant move on Monday, President Joe Biden's administration proposed a new rule mandating private health plans to cover long-acting injectable pre-exposure prophylaxis (PrEP) drugs without cost-sharing. This proposal is part of a broader effort to enhance healthcare access, which also includes requiring health plans to cover contraceptives without additional costs. The proposed rule addresses enforcement of the Affordable Care Act, stipulating that private health care plans “to cover every FDA-approved contraceptive drug or drug-led combination product without cost-sharing unless the plan also covers a therapeutic equivalent without cost-sharing.” Drug-led combination products refer to therapeutic or diagnostic items delivered via a medical device, such as a syringe. Carl Schmid, executive director of the HIV+ Hepatitis Policy Institute, emphasized the importance of this coverage requirement. He said, “With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with zero cost-sharing will help jump-start the use of more effective forms of PrEP and lead to fewer HIV transmissions.” Although Biden did not directly mention PrEP coverage, he criticized Republicans for their efforts to restrict family planning services, particularly following the recent U.S. Supreme Court ruling that overturned Roe v. Wade. The President reiterated his administration’s pledge to protect reproductive healthcare access and urged Congress to restore reproductive freedom and safeguard the right to contraception once and for all. #Queer Up Health